Biotechnology

The need for universal and massive testing across the population has led to a race for technology innovations for COVID-19 diagnostics.

The current outbreak of a novel coronavirus (2019-nCoV) has hit China in the past month and spread to 25 nations. Early detection and diagnosis are essential to reduce the prevalence of infectious diseases and to prevent them from becoming epidemic or even pandemic.

As the point-of-care biosensor market is expected to expand to $33 billion by 2027, investing in the right technology and business model now is paramount to success over the next decade.

IDTechEx will be hosting a free webinar on Tuesday 21 November titled Medical Biosensors for Monitoring and Diagnostics.